Avricore Health (AVCRF) EBT Margin (2009 - 2025)
Avricore Health (AVCRF) posted quarterly EBT Margin of 1003.84% for Q3 2025, down 98920.0% YoY from N/an in Q3 2024, and up 38.73% sequentially from 1638.46% in Q2 2025.
Avricore Health (AVCRF) EBT Margin (2009 - 2025) Analysis & Trends
Avricore Health has disclosed EBT Margin across 16 years of filings, most recently posting 1003.84% for Q3 2025.
- In Q3 2025, EBT Margin fell 98920.0% year-over-year to 1003.84%; the TTM figure through Sep 2025 stood at 64.79% (down 6709.0% YoY), while the FY2025 annual figure was 256.86%, down 25956.0% from the prior year.
- EBT Margin climbed to 1003.84% in Q3 2025, from 1638.46% in the prior quarter.
- Over the last five years, EBT Margin for AVCRF reached as high as 14.1% in Q1 2024 and fell as low as 1638.46% in Q2 2025.
- The 5-year median for EBT Margin is 37.25% (2021), against an average of 299.6%.
- Annual changes were most pronounced in 2022 — EBT Margin jumped 121087 bps — and 2025, when it tumbled 164364 bps.
- A 5-year view of EBT Margin shows it stood at 523.96% in 2021, then surged by 95 bps to 24.19% in 2022, then jumped by 121 bps to 5.14% in 2023, then tumbled by 385 bps to 14.64% in 2024, then sank by 6756 bps to 1003.84% in 2025.
- According to Business Quant data, EBT Margin over the past three periods registered 1003.84%, 1638.46%, and 17.3% for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -6.95% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 15.76% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 20.75% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 31.16% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -12.17% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 22.23% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 7.90% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 14.39% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 22.14% |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,003.84% |
| Jun 30, 2025 | -1,638.46% |
| Mar 31, 2025 | -17.30% |
| Sep 30, 2024 | -14.64% |
| Jun 30, 2024 | 5.17% |
| Mar 31, 2024 | 14.10% |
| Dec 31, 2023 | 5.14% |
| Sep 30, 2023 | -29.84% |
| Jun 30, 2023 | -51.85% |
| Mar 31, 2023 | -30.72% |
| Dec 31, 2022 | -24.19% |
| Sep 30, 2022 | -31.53% |
| Jun 30, 2022 | -117.70% |
| Mar 31, 2022 | -434.88% |
| Dec 31, 2021 | -523.96% |
| Sep 30, 2021 | -42.97% |
| Jun 30, 2021 | -1,328.57% |
| Mar 31, 2021 | -126.85% |
| Dec 31, 2020 | -72.53% |
| Sep 30, 2020 | 310.22% |